Gilead Sciences Stock: HIV Success Fuels Analyst Optimism
Gilead Sciences' biotech stock continues its upward trajectory as multiple investment banks raise price targets, buoyed by strong quarterly results...
Accomplished economist, entrepreneur, and profound expert in financial markets.
Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.
Gilead Sciences' biotech stock continues its upward trajectory as multiple investment banks raise price targets, buoyed by strong quarterly results...
Expedia's shares surged 13.5% to a 52-week high of $212.06 on Friday, capping a 59.75% annual gain, fueled by stronger-than-expected...
SoundHound AI, a leader in voice recognition technology, shattered expectations with its Q2 2025 performance, reporting revenue of $42.7 million—a...
Despite reporting solid second-quarter results, The Trade Desk’s shares plummeted over 30% in after-hours trading to $61.72, marking one of...
Bechtle's second-quarter earnings revealed a stark contrast between revenue growth and profit declines, leaving investors with mixed signals. The German...
Sony surprised markets with a robust comeback, reporting a 36% surge in operating profit to ¥340 billion ($2.3 billion) for...
Motorola Solutions surpassed analyst expectations with robust second-quarter results, reporting adjusted earnings of $3.57 per share—well above the projected $3.36—and...
Apple investors breathed a sigh of relief as the tech giant secured an exemption from proposed 100% tariffs on semiconductor...
Conocophillips delivered a paradoxical second-quarter performance, with record production volumes contrasting sharply with declining profits. The oil giant reported a...
Bayer's latest quarterly results have left investors divided, as a surprise €2.1 billion adjusted operating profit—boosted by a €150 million...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.